CBRC and KAU Collaborate to sign a research agreement on The Role of Gut Microbes in Development of Malignant Pancreatic Cysts in Saudi Patients

Aug 01 2019

The Computational Bioscience Research Center (CBRC) at King Abdullah University of Science and Technology (KAUST) and GI Oncology Unit (GIOU) of King Abdulaziz University Hospital at King Abdulaziz University, have signed a research agreement on “The Role of Gut Microbes in Development of Malignant Pancreatic Cysts in Saudi Patients.”

The collaborative research is funded through KAUST Center Partnership Funds. To the best of our knowledge, the research is the first one in the Kingdom to use Medical Metagenomics in clinical pancreatic cancer research. 

The study aims to investigate if microbial communities in pancreatic cysts can differentiate cysts that turn into a malignant form from those that remain benign. The successful outcomes could open the way to novel diagnostic methods of pancreatic malignancies and more closer precision medicine. PI at GIOU is Assistant Professor Emah S. Aljahdli, and CBRC PI is Professor Vladimir Bajic.

combined logo.jpg